参考文献/References:
[1]Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas [J]. N Engl J Med, 2015, 372(26): 2481-2498.
[2]杜 伟,陈义兵,魏新亭,等. 2016版《WHO中枢神经系统肿瘤分类》更新解读[J]. 中华神经外科杂志,2016,32(11):1095-1098.
[3]Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme [J]. Science, 2008, 321(5897): 1807-1812.
[4]Bush NA, Butowski N. The effect of molecular diagnostics on the treatment of glioma [J]. Curr Oncol Rep, 2017, 19(4): 26.
[5]Olar A, Wani KM, Alfaro-Munoz KD, et al. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas [J]. Acta Neuropathol, 2015, 129(4): 585-596.
[6]Beiko J, Suki D, Hess KR, et al. IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection [J]. Neuro Oncol, 2014, 16(1): 81-91.
[7]赵 焕,白 岩,王梅云. 多模态磁共振成像技术在脑胶质瘤基因分型及预后评估中的研究进展[J]. 磁共振成像,2021,12(9):98-102.
[8]Lu CF, Hsu FT, Hsieh KL, et al. Machine learning-based radiomics for molecular subtyping of gliomas [J]. Clin Cancer res, 2018, 24(18): 4429-4436.
[9]Ditmer A, Zhang B, Shujaat T, et al. Diagnostic accuracy of MRI texture analysis for grading gliomas [J]. J Neurooncol,2018, 140(3): 583-589.
[10]Qian Z, Li Y, Wang Y, et al. Differentiation of glioblastoma from solitary brain metastases using radiomic machine-learning classifiers [J]. Cancer Lett, 2019, 451: 128-135.
[11]Mouraviev A, Detsky J, Sahgal A, et al. Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery [J]. Neuro Oncol, 2020, 22(6): 797-805.
[12]Hyare H, Rice L, Thust S, et al. Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status [J]. Eur J Radiol, 2019, 114: 120-127.
[13]Maynard J, Okuchi S, Wastling S, et al. World Health Organization grade II/III glioma molecular status: prediction by MRI morphologic features and apparent diffusion coefficient [J]. Radiology, 2020, 296(1): 111-121.
[14]Compes P, Tabouret E, Etcheverry A, et al. Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016 [J]. Neuro-oncology, 2019, 142(3): 511-520.
[15]Yu J, Shi Z, Lian Y, et al. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma [J]. Eur Radiol, 2017, 27(8): 3509-3522.
[16]Liu X, Li Y, Li S, et al. Mutation-specific radiomic signature in lower-grade gliomas [J]. Aging (Albany NY), 2019, 11(2): 673-696.
[17]Kim M, Jung SY, Park JE, et al. Diffusion-and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma [J]. Eur Radiol, 2020, 30(4): 2142-2151.
[18]Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine [J]. Nat Rev Clin Oncol, 2017, 14(12): 749-762.
[19]Gore S, Chougule T, Jagtap J, et al. A review of radiomics and deep predictive modeling in glioma characterization [J]. Acad Radiol, 2021, 28(11): 1599-1621.
[20]王天达,席海蛟,袁 涛,等. 较低级别胶质瘤相关基因表型的形态与功能MR研究进展[J]. 临床放射学杂志,2021,40(10):2037-2041.
相似文献/References:
[1]付 锴 江普查 宫 睿 王 伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(03):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]崔焕喜,柳 琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[3]闫 珊 徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(03):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[4]罗似亮 夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(03):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[5]呼铁民 褚会松 田 甜 王昆鹏 杨国军 杨立军 王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(03):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[6]汪超甲 综述 王 辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[7]高剑峰 姚庆和 李晓辉 龙宇波 陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(03):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[8]刘 靖 吴立权 黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[9]刘 炎 杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]
[10]刘东明 胡新华 刘 永 陈 玖 刘宏毅.脑胶质瘤病人静息态默认模式网络研究进展[J].中国临床神经外科杂志,2018,(12):821.[doi:10.13798/j.issn.1009-153X.2018.12.022]